RecruitingNCT07128966
Direct to Patient Minimal Risk Biospecimen and Data Collection Research
Joined Bio - JB-MR-250225, Direct to Patient Minimal Risk Research
Sponsor
Joined Bio
Enrollment
100,000 participants
Start Date
Apr 1, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to help researchers better understand health conditions and develop improved tests, treatments, and cures for diseases. Joined Bio collects health data, lifestyle information, biological samples, and feedback from participants and provides this to qualified research partners.
Eligibility
Min Age: 18 YearsMax Age: 90 Years
Inclusion Criteria7
- Male or female, that are adults \[have reached the Age of Majority = aged 18 to 90 in most US states; aged 19-90 in Alabama or Nebraska; aged 21-90 in Mississippi or Puerto Rico\].
- Have reviewed and signed a consent or e-consent form for this study. If a person with diminished decision-making capacity, their Legally Authorized Representative has reviewed and signed the consent for on their behalf.
- Be willing to comply with all study procedures and be available for the duration of the study.
- Meets requirements of a current request for research participation (e.g. has previous diagnosis of a medical condition of interest or laboratory results within a specific range).
- Pregnant women may be enrolled in this study in accordance with 45 CFR Part 46 Subpart B.
- Prisoners or children
- Unable to provide the requested biospecimen(s), data or feedback without placing the individual at risk.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERObservation
This is non-interventional, observational only
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07128966
Related Trials
Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
NCT072629831 location
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
NCT071696301 location
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
NCT06963827153 locations
Increasing Physical Activity Through Social Support and Stress Resilience
NCT068968251 location
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
NCT07160244165 locations